Should incidental asymptomatic angiographic stenoses and occlusions be treated in patients with peripheral arterial disease?
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Authors
Keeling, Aoife NNaughton, Peter A
Khalidi, Karim
Ayyoub, Alaa S
Kelly, Cathal K
Leahy, Austin L
Bouchier-Hayes, David J
Athanasiou, Thanos
Lee, Michael J
Affiliation
Department of Academic Radiology, Beaumont Hospital, Beaumont Road, Dublin 9, Ireland.Issue Date
2009-09MeSH
AdultAged
Angiography
Comorbidity
Female
Humans
Incidence
Incidental Findings
Intermittent Claudication
Ireland
Male
Middle Aged
Peripheral Vascular Diseases
Retrospective Studies
Risk Assessment
Risk Factors
Survival Analysis
Survival Rate
Vascular Surgical Procedures
Metadata
Show full item recordCitation
Should incidental asymptomatic angiographic stenoses and occlusions be treated in patients with peripheral arterial disease? 2009, 20 (9):1133-40 J Vasc Interv RadiolJournal
Journal of vascular and interventional radiology : JVIRDOI
10.1016/j.jvir.2009.05.035PubMed ID
19640739Abstract
The clinical importance of angiographically detected asymptomatic lower-limb stenoses and occlusions is unknown. This study aims to (i) assess the clinical outcome of asymptomatic lesions in the lower limb, (ii) identify predictors of clinical deterioration, and (iii) determine which asymptomatic lower-limb lesions should be treated at presentation.All 918 patients undergoing peripheral angiography with or without angioplasty over a period of 7.5 years (January 1999 through June 2006) at a single institution were retrospectively evaluated. One hundred twenty-two patients (54% men; mean age, 70.3 years; age range, 41-91 y) with angiographic stenoses (> or =50%) or occlusions on the asymptomatic leg were included. The composite endpoint of interest was major adverse clinical outcome (MACO) of the asymptomatic limb at clinical follow-up, which was defined as the development of intermittent claudication (IC), critical limb ischemia (CLI), or need for subsequent endovascular or surgical revascularization. Actuarial freedom from MACO was assessed with Kaplan-Meier curves and multivariable Cox proportional-hazards regression.
During a 4.2-year mean follow-up in 122 patients with significant concomitant asymptomatic disease, 32.8% of patients developed symptoms (13.9% with IC, 18.9% with CLI); 42.5% of these cases required revascularization. Cox regression revealed two independent predictors of MACO on the asymptomatic side: contralateral below-knee amputation (BKA; hazard ratio, 2.93; 95% CI, 1.21-7.10; P = .01) and statin treatment (hazard ratio, 3.56; 95% CI, 1.56-8.13; P = .003).
Asymptomatic peripheral angiographic stenoses and occlusions become symptomatic in one third of patients, necessitating treatment in 13.9% overall. Previous contralateral BKA and statin use were independent predictors of adverse outcome in this population. Close clinical follow-up and appropriate risk factor modification are recommended.
Item Type
ArticleLanguage
enISSN
1535-7732ae974a485f413a2113503eed53cd6c53
10.1016/j.jvir.2009.05.035
Scopus Count
Collections
Related articles
- Subintimal angioplasty: predictors of long-term success.
- Authors: Keeling AN, Khalidi K, Leong S, Given MF, McGrath FP, Athanasiou T, Lee MJ
- Issue date: 2009 Aug
- Laser atherectomy for lower extremity revascularization: An adjunctive endovascular treatment option.
- Authors: Zhou W, Bush RL, Lin PH, Peden EK, Lumsden AB
- Issue date: 2006 Aug-Sep
- Endovascular surgery for chronic limb ischaemia. Factors predicting immediate outcome on the basis of a nationwide vascular registry.
- Authors: Vainio E, Salenius JP, Lepäntalo M, Luther M, Ylönen K
- Issue date: 2001
- Factors affecting symptomatic vs asymptomatic vein graft stenoses in lower extremity bypass grafts.
- Authors: Landry GJ, Liem TK, Mitchell EL, Edwards JM, Moneta GL
- Issue date: 2007 Sep
- Postoperative outcomes for patients undergoing elective revascularization for critical limb ischemia and intermittent claudication: a subanalysis of the Coronary Artery Revascularization Prophylaxis (CARP) trial.
- Authors: Raghunathan A, Rapp JH, Littooy F, Santilli S, Krupski WC, Ward HB, Thottapurathu L, Moritz T, McFalls EO, CARP Investigators
- Issue date: 2006 Jun